EDGAR Filing Documents for 0001193125-13-251913

Form POSASR - Post-effective Amendment to an automatic shelf registration statement:

SEC Accession No. 0001193125-13-251913

Filing Date

2013-06-07

Accepted

2013-06-07 17:20:53

Documents

Effectiveness Date

2013-06-07

Document Format Files

Seq	Description	Document	Type	Size
1	POSASR	d551126dposasr.htm	POSASR	97292
2	EX-4.6	d551126dex46.htm	EX-4.6	304498
3	EX-5.1	d551126dex51.htm	EX-5.1	27252
4	EX-24.1	d551126dex241.htm	EX-24.1	21554
5	GRAPHIC	g551126cm58a.jpg	GRAPHIC	3531
6	GRAPHIC	g551126cm59.jpg	GRAPHIC	2447
	Complete submission text file	0001193125-13-251913.txt		460423

Mailing Address 215 FIRST STREET SUITE 7 CAMBRIDGE MA 02142

Business Address 215 FIRST STREET SUITE 7 CAMBRIDGE MA 02142 617-444-8424

Sarepta Therapeutics, Inc. (Filer) CIK: 0000873303 (see all company filings)